The temporary program, which runs until the end of 2027, is the first opportunity for most older adults to get GLP-1s, short for glucagon-like peptide-1 receptor agonists, covered by insurance when used strictly for weight loss
The therapeutic class is experiencing unprecedented demand as prescriber awareness of pleiotropic benefits, including kidney disease event reduction and major adverse cardiovascular event reduction, reshapes treatment algorithms
They can help explain your individual risk, lab results, and timeline
- Oral semaglutide (only FDA approved for diabetes treatment) and injectable liraglutide, (FDA approved for obesity treatment as Saxenda,) lead to relatively modest amount of weight loss
Read Our Blog: What is the best time to take Glutathione How Much Glutathione Should You Take
The website collects and stores personal and non-personal information about you through cookies and other technology, including your IP address